A possible role for π-stacking in the self-assembly of amyloid fibrils

FASEB Journal

Volumn 16, Issue 1, 2002, Pages 77-83

  Gazit, Ehud ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Alzheimer's disease; Amyloid related proteins; Aromatic residue

Indexed keywords

AMYLOID;

ALZHEIMER DISEASE; HUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; REVIEW; STRUCTURE ACTIVITY RELATION;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMINO ACIDS, AROMATIC; AMYLOID; AMYLOID BETA-PROTEIN; AMYLOIDOSIS; ANIMALS; ANTIGENS, SURFACE; FUNGAL PROTEINS; GLYCOPROTEINS; HUMANS; MILK PROTEINS; MODELS, CHEMICAL; PEPTIDE FRAGMENTS; PRIONS;

EID: 0036135139     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.01-0442hyp     Document Type: Review

References (48)

1. Controlling self-assembly
2. π-π interactions in self-assembly
3. Aromatic π-stacking in solution as revealed through the aggregation of phenylacetylene macrocycles
4. π-stacking interactions: Alive and well in proteins
5. Aromatic van der Waals clusters: Structure and nonrigidity
6. Arene-arene interactions: Electrostatic or charge transfer
7. Models of amyloid seeding in Alzheimer disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins
8. From the globular to the fibrous state: Protein structure and structural conversion in amyloid formation
9. Protein misfolding, evolution and disease
10. Review: History of the amyloid fibril
11. The 'correctly-folded' state of proteins: Is it a metastable state?
12. Analysis of the structural and functional elements of the minimal active fragment of islet amyloid polypeptide (IAPP): An experimental support for the key role for the phenylalanine residue in amyloid formation
13. Amino-acid substitution matrices from an information theoretic perspective
14. Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties
15. Islet amyloid polypeptide: Pinpointing amino acid residues linked to amyloid-fibril formation
16. Islet amyloid. A long-recognized but underappreciated pathological feature of type 2 diabetes
17. Preparation of synthetic human islet amyloid polypeptide (IAPP) in a stable conformation to enable study of conversion to amyloid-like fibrils
18. Conformational transitions of Islet amyloid polypeptide (IAPP) in amyloid formation in vitro
19. Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin
20. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis
21. Arrest of beta-amyloid fibril formation by a pentapeptide ligand
22. Modifiedpeptide inhibitors of amyloid-beta-peptide polymerization
23. Beta-sheet breaker peptides nhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy
24. Amyloid fibril formation by Aβ 16-22, a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state NMR
25. Medin: An-integral fragment of aortic smooth muscle cell-produced lactadherin forms the most common human amyloid
26. Senile aortic amyloid. Evidence for two distinct-forms of localized deposits
27. Creation of amyloid fibrils from mutant Asn187 gelsolin peptides
28. The N-terminal segment of protein AA determines its fibrillogenic property
29. Prion protein amyloid and neurodegeneration
30. Abnormal properties of prion protein with insertional mutations in different cell types
31. Support for the prion hypothesis for inheritance of a phenotypic trait in yeast
32. Yeast prions and their prion-forming domain
33. Creating a protein-based element of inheritance
34. An amyloidforming peptide from the yeast prion Sup35 reveals a dehydrated beta-sheet structure for amyloid
35. The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are-seeded by beta-amyloid: Is NAC a common trigger or target in neurodegenerative disease?
36. In vitro synthesis of 'amyloid' fibrils from insulin, calcitonin-and parathormone
37. Homology of calcitonin with the amyloid-related proteins
38. Calcitonin-like immunoreactivity of amyloid fibrils in medullary thyroid carcinomas. An immunoelectron microscope study
39. A stop-codon mutation in the BRI gene associated with familial British dementia
40. Misfolding the way to disease
41. Controlling polymerization of beta-amyloid and prion-derived peptides with synthetic small molecules ligands
42. A short synthesis of the β-amyloid (Aβ) aggregation inhibitor 3-p-toluoy1-2-[4′-(3-diethylaminopropoxy)-phenyl]-benzofuran
43. Beta-amyloid neurotoxicity requires fibril formation and is-inhibited by congo red
44. Interaction of the anthracycline 4′-iodo-4′-deoxydoxorubicln with amyloid fibrils: Inhibition of amyloidogenesis
45. Treatment of AL amyloidosis with 4′-iodo-4′-deoxydoxorubicin: An update
46. 4′-Iodo-4′-deoxydoxorubicin disrupts the fibrillar structure of transthyretin amyloid
47. Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro